2017. DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO. Proceedings of the International Conference on Applied Science and Health. 2 (Sep. 2017), 81–85.